In the USA, the FDA has recently approved the Alcon PanOptix IOL for use in cataract surgery. This is a trifocal IOL design which is designed to give a wide range of vision using diffractive light-splitting technology. It is an improvement from its predecessors, particularly from certain bifocal designs. This lens has become popular in many countries outside the USA and has a significant rack record of success. But is it the fountain of youth for restoring great vision?
0 Comments